MedTrace Logo

Whole Genome Sequencing in the Neonatal Intensive Care Unit

NCT03721458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2021-02-01

No results posted yet for this study

Summary

This research is being done to see if whole genome sequencing (WGS) improves the diagnosis of patients in the NICU. Using WGS in this way, which is relatively new, researchers at Penn State College of Medicine will look at approximately 5000 genes that are known to be associated with genetic diseases to see if the neonatal patient has a known disease causing mutation. Comparing the parents' DNA with the child's will help the investigators better understand the child's DNA.

Conditions

  • Genetic Diseases, Inborn

Interventions

OTHER

Sequence

Potentially identifying genetic defects that could have clinical significance

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • James Broach, PhD · Milton S. Hershey Medical Center

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-28
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721458 on ClinicalTrials.gov